Jay Achar

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Xpert Ultra on nasopharyngeal swabs detects one-third of pulmonary tuberculosis: a nested case-control study in South African primary care.

Xpert Ultra on nasopharyngeal swabs detects one-third of pulmonary tuberculosis: a nested case-control study in South African primary care.

Journal: Research square

Published: July 03, 2026

Detection of Aerosolized Mycobacterium tuberculosis DNA From Adults Being Investigated for Pulmonary Tuberculosis via an Electrostatic Sampler in a South African Primary Care Setting.

Detection of Aerosolized Mycobacterium tuberculosis DNA From Adults Being Investigated for Pulmonary Tuberculosis via an Electrostatic Sampler in a South African Primary Care Setting.

Journal: Open forum infectious diseases

Published: July 08, 2025

Waste to worth: diagnostic accuracy of Xpert MTB/XDR on contaminated liquid cultures to salvage the detection of drug-resistant tuberculosis.

Waste to worth: diagnostic accuracy of Xpert MTB/XDR on contaminated liquid cultures to salvage the detection of drug-resistant tuberculosis.

Journal: Journal of clinical microbiology

Published: July 01, 2025

Waste to Worth: A diagnostic accuracy of Xpert MTB/XDR on contaminated liquid cultures to salvage the detection of drug-resistant tuberculosis.

Waste to Worth: A diagnostic accuracy of Xpert MTB/XDR on contaminated liquid cultures to salvage the detection of drug-resistant tuberculosis.

Journal: Research square

Published: April 29, 2025

Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis.

Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis.

Journal: The Lancet. Infectious diseases

Published: November 25, 2024

Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis.

Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis.

Journal: The Lancet. Child & adolescent health

Published: April 26, 2024

Correction: The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan.

Correction: The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan.

Journal: PLOS global public health

Published: April 02, 2024

Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study.

Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study.

Journal: The Lancet. Infectious diseases

Published: February 15, 2024

Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region.

Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region.

Journal: IJTLD open

Published: January 23, 2024

A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020.

A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020.

Journal: IJTLD open

Published: November 02, 2023

Household drug-resistant TB contact tracing in Tajikistan.

Household drug-resistant TB contact tracing in Tajikistan.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: September 26, 2023

Trends in the availability and prices of quality-assured tuberculosis drugs: a systematic analysis of Global Drug Facility Product Catalogs from 2001 to 2024.

Trends in the availability and prices of quality-assured tuberculosis drugs: a systematic analysis of Global Drug Facility Product Catalogs from 2001 to 2024.

Journal: Globalization and health

Published: September 09, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026